Subgroup analyses of a randomized sequential open-label study (SWITCH) to evaluate efficacy and safety of sorafenib (SO)/sunitinib (SU) versus SU/SO in the treatment of metastatic renal cell cancer (mRCC).-Reference-Cited by-同舟云学术

Subgroup analyses of a randomized sequential open-label study (SWITCH) to evaluate efficacy and safety of sorafenib (SO)/sunitinib (SU) versus SU/SO in the treatment of metastatic renal cell cancer (mRCC).

Published:2014-05-20 Issue:15_suppl Volume:32 Page:4567-4567
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Goebell Peter J.¹,Vervenne Walter²,De Santis Maria³,Von Weikersthal Ludwig Fischer⁴,Lerchenmuller Christian A.⁵,Zimmermann Uwe⁶,Bos Monique M.E.M.⁷,Freier Werner⁸,Schirrmacher-Memmel Silke⁹,Staehler Michael D.¹⁰,Pahernik Sascha¹¹,Los Maartje¹²,Schenk Marcus¹³,Flörcken Anne¹⁴,Van Arkel Cornelis¹⁵,Hauswald Kirsten¹⁶,Indorf Martin¹⁶,Gottstein Dana¹⁷,Eichelberg Christian¹⁸,Michel Maurice Stephan¹⁹

Affiliation:

1. AURONTE (Urologische Klinik und Klinik fuer Haematologie und Onkologie (Med5); Universitaetsklinikum Erlangen), Erlangen, Germany

2. Deventer Ziekenhuis, Deventer, Netherlands

3. LBI-ACR Vienna and KFJ-Hospital, Vienna, Austria

4. Gesundheitszentrum St Marien, Amberg, Germany

5. Private Practice for Oncology, Muenster, Germany

6. University Hospital Greifswald, Greifswald, Germany

7. Department of Internal Medicine. Reinier de Graaf Hospital, Delft, Netherlands

8. Onkologische Praxis, Hildesheim, Germany

9. MVZ Osthessen GmbH, Fulda, Germany

10. Department of Urology, University Hospital Munich-Grosshadern, Ludwig Maximilian University, Munich, Germany

11. Universitätsklinikum Heidelberg, Heidelberg, Germany

12. St Antonius Hospital, Nieuwegein, Netherlands

13. University Hospital Essen, Essen, Germany

14. Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Campus Virchow Klinikum, Berlin, Germany

15. Slingeland Ziekenhuis, Doetinchem, Netherlands

16. iOMEDICO AG, Freiburg, Germany

17. ICRC-Weyer GmbH, Berlin, Germany

18. Caritas-Krankenhaus St. Josef, Regensburg, Germany

19. Department of Urology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2014.32.15_suppl.4567

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysis;Cochrane Database of Systematic Reviews;2023-05-04

2. Targeted therapy for metastatic renal cell carcinoma;Cochrane Database of Systematic Reviews;2020-10-14

3. Nierenzellkarzinom;Weiterbildung Onkologie;2016

4. Nierenzellkarzinom;Der Urologe;2015-05

5. Nierenzellkarzinom;Der Onkologe;2014-11-30